Literature DB >> 5285375

The metabolic fate of warfarin: studies on the metabolites in plasma.

R J Lewis, W F Trager.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5285375     DOI: 10.1111/j.1749-6632.1971.tb46900.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  11 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Variability in response to drugs.

Authors:  M D Rawlins
Journal:  Br Med J       Date:  1974-10-12

Review 3.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

4.  Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.

Authors:  S E Smith; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Influence of allopurinol on drug metabolism in man.

Authors:  M D Rawlins; S E Smith
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

6.  Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man.

Authors:  W Dieterle; J W Faigle; C Montigel; M Sulc; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

7.  Further insight into the stereoselective interaction between warfarin and cimetidine in man.

Authors:  I Niopas; S Toon; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

8.  Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.

Authors:  C Banfield; R O'Reilly; E Chan; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

9.  Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.

Authors:  R A O'Reilly; W F Trager; C H Motley; W Howald
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Phenprocoumon metabolites in human plasma; characterization by HPLC and GC-MS.

Authors:  J X de Vries; R Zimmermann; J Harenberg
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.